Navigation Links
ASH honors David Ginsburg, M.D., and Richard Aster, M.D., with 2012 Henry M. Stratton Medal
Date:8/27/2012

The Henry M. Stratton Medal is named after the late Henry Maurice Stratton, co-founder of Grune and Stratton, the medical publishing house that first published ASH's journal Blood. The prize honors senior investigators whose contributions to hematology are well-recognized and have taken place over a period of several years. This year, for the first time, the Stratton Medal will be awarded to two individuals, one in basic research and the other in clinical/translational research. Dr. Ginsburg will receive the 2012 Stratton Medal for Basic Research for his many seminal scientific contributions in characterizing the molecular and genetic basis of inherited bleeding and clotting disorders. Dr. Aster will receive the 2012 Stratton Medal for Clinical/Translational Research for his many breakthroughs in platelet immunology, mainly in drug-induced antibodies, human leukocyte antigen anti-platelet antibodies, and neonatal thrombocytopenia.

Dr. Ginsburg is the James V. Neel Distinguished University Professor of Internal Medicine, Human Genetics, and Pediatrics at the University of Michigan and an Investigator of the Howard Hughes Medical Institute. Dr. Ginsburg has dedicated his medical career to understanding the clotting system and has made many contributions to the field of hematology, including identifying the genetic basis of numerous clotting disorders, such as thrombotic thrombocytopenic purpura (TTP), combined deficiency of Factor V and Factor VIII, and von Willebrand disease (VWD). Beginning with the cDNA cloning of VWF in 1985, Dr. Ginsburg and his colleagues demonstrated how different mutations in the VWF gene resulted in the variable subtypes of VWD, a focus which also led to his group's identification and cloning of the ADAMTS13 gene as the cause of TTP.

A member of ASH since 1985, Dr. Ginsburg has served in numerous roles within the Society, including serving as Chair of the Committee on Scientific Affairs, Councillor on the
'/>"/>

Contact: Claire Gwayi-Chore
cgwayi-chore@hematology.org
202-776-0544
American Society of Hematology
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Amyotrophic Lateral Sclerosis Association honors Dr. Robert Baloh, M.D.
2. ASH honors Bruce R. Blazar, M.D., and Carl H. June, M.D., with 2012 Ernest Beutler Lecture and Prize
3. ASH honors Margaret A. Goodell, Ph.D., with 2012 William Dameshek Prize
4. David H. Koch donates $10 million to Mount Sinais Jaffe Food Allergy Institute
5. Special Needs Spotlight: Former SFMTA Board Member Bruce Oka Receives Treatment with San Francisco Sedation Dentist Dr. David Blende
6. Public health expert David Dausey calls BPA ban hollow victory
7. Edith Mitchell, M.D., FACP, named 2012 recipient of ASCO Humanitarian Award
8. ASH awards Timothy J. Ley, M.D., with 2012 E. Donnall Thomas Lecture and Prize
9. Author, Speaker Richard London Battles Parkinson’s with an Active Lifestyle and the Desire to Give Back
10. EMBO Gold Medal 2012 awarded to Jiri Friml
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ... July 28, 2015 , ... ADLINK Technology, a leading ... devices that enable the Internet of Things (IoT), announced its new medical panel ... provide exceptional computing power and multitasking capabilities. The MLC 4-21 is completely fanless, ...
(Date:7/28/2015)... ... July 28, 2015 , ... OrthAlign, Inc., ... its ORTHALIGN PLUS® system, a palm-sized, single-use navigation device for Total Hip Arthroplasty ... precision with practicality in a revolutionary way for Total Knee Arthroplasty surgeries and ...
(Date:7/28/2015)... ... July 28, 2015 , ... On July 16th ... to schedule the hearing of proposed bills and laws revolving the implementation of a ... to date. Some vigilante ministers are continuing to hand out clean needles to drug ...
(Date:7/28/2015)... ... July 28, 2015 , ... BiologicsMD, Inc. , a ... the treatment of bone disorders and conditions of hair loss, announced that the ... of Collagen Binding-Domain and Parathyroid Hormone". The issued patent claims methods of use ...
(Date:7/28/2015)... ... ... Fertility specialist Dr. Lisa Hasty of Atlanta Center for Reproductive ... Atlanta Magazine's annual Top Doctors issue, Dr. Hasty has been recognized for the fifth ... metro area as one of the most respected doctors in Reproductive Endocrinology. , “I’m ...
Breaking Medicine News(10 mins):Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 2Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 3Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 2Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 3Health News:Needle Exchange Programs Are Delayed in Legislation, West Palm Beach Drug Rehab Comments 2Health News:Needle Exchange Programs Are Delayed in Legislation, West Palm Beach Drug Rehab Comments 3Health News:BiologicsMD, Inc. Announces Additional US Patent Issuance Covering Company’s Pipeline of Targeted Therapies 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 3
... shorts in football prints and innerwear with net inserts ... lingerie designers are experimenting with.,Overall, the trend in lingerie ... with a hint of romance. The seductive undergarments require ... being tried with embroidery. The garments aren't so opulent, ...
... 7,000 cancer tumour samples for researchers all over the world ... the world over are hailing this step as a major ... truly international. ,"Cancer is not just one disease, ... misbehaving. Since it is multiple diseases, you have to have ...
... death has been reported in Egypt, the most populous North ... woman //, indeed died as a consequence of the highly ... from Nawa village in Qalyubiya, some 40 km north of ... she had been treated for flu-like symptoms, the health ministry ...
... the avian influenza H5N1 virus is receiving samples from across ... arrive each week, packed in ice boxes. // These samples ... chicken deaths and from routine surveillance sites. , ... Animal Disease Laboratory in Bhopal, is running out of space ...
... in kidney transplant recipients can be used in treatment ... 40 years ago, is still used to prevent the ... ,In around the 1960s, Roy Calne showed that ... this finding, a combination of azathioprine and corticosteroids were ...
... the direction of development of prosthetic limbs researchers at University ... by alcohol and hydrogen. // ,As it appears ... than the body's own. ,Two types of ... Institute at the University of Texas in Dallas, working with ...
Cached Medicine News:Health News:Romantic and discreet trends in lingerie 2Health News:Azathioprine Can Soon Revolutionize Eczema Treatment 2
(Date:7/28/2015)... 2015  Xencor, Inc. (NASDAQ: XNCR ), a ... treatment of autoimmune diseases, asthma and allergic diseases, and ... financial results after the market closes on Tuesday, August ... conference call the same day at 4:30 p.m. ET ... provide a corporate update. The live call ...
(Date:7/28/2015)...  Champions Oncology, Inc. (OTC: CSBR), engaged in the ... the development and use of oncology drugs, today announced ... 2015. Fourth Quarter and Recent Business Highlights: ... prior year period result , Procured a quarterly ... Joel Ackerman, Champions Oncology CEO, stated, "The end of ...
(Date:7/28/2015)... July 28, 2015  Cepheid (Nasdaq: CPHD ... and portable clinical molecular diagnostic system designed to ... market.  At just 9 inches tall, and weighing ... the same high quality PCR-based Xpert® cartridges as ... accurate clinical molecular diagnostic tests to be performed ...
Breaking Medicine Technology:Xencor to Host Second Quarter 2015 Financial Results Webcast and Conference Call on August 4, 2015 2Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 2Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 3Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 4Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 5Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 6Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 7Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 8Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 9Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 10Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 11World's First "Go-Anywhere" Molecular Diagnostic System Unveiled at AACC 2World's First "Go-Anywhere" Molecular Diagnostic System Unveiled at AACC 3World's First "Go-Anywhere" Molecular Diagnostic System Unveiled at AACC 4
... Expand Testing Using Cellular ... Antioxidant Activity Assay, ... with the release of results from a new study,showing Wild ... red grapes and strawberries in an expanded,test using the Cellular ...
... Oct. 8 Vical Incorporated (Nasdaq: VICL ... nonclinical data,demonstrating that the company,s Vaxfectin(R) adjuvant may ... vaccines and,peptide-based cancer vaccines. Alain P. Rolland, Pharm.D., ... present the data today,Wednesday, October 8, at the ...
Cached Medicine Technology:Wild Blueberries Take Top Spot in New Antioxidant Research Study 2Wild Blueberries Take Top Spot in New Antioxidant Research Study 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: